Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Albert Y. Hung"'
Autor:
Mario H. Flores‐Torres, Chadwick W. Christine, Kjetil Bjornevik, Samantha A. Molsberry, Albert Y. Hung, Brian C. Healy, Deborah Blacker, Michael A. Schwarzschild, Alberto Ascherio
Publikováno v:
Movement Disorders.
Autor:
Alain Ndayisaba, Ariana T. Pitaro, Andrew S. Willett, Kristie A. Jones, Claudio Melo de Gusmao, Abby L. Olsen, Jisoo Kim, Eero Rissanen, Jared K. Woods, Sharan R. Srinivasan, Anna Nagy, Amanda Nagy, Merlyne Mesidor, Steven Cicero, Viharkumar Patel, Derek H. Oakley, Idil Tuncali, Katherine Taglieri-Noble, Emily C. Clark, Jordan Paulson, Richard C. Krolewski, Gary P. Ho, Albert Y. Hung, Anne-Marie Wills, Michael T. Hayes, Jason P. Macmore, Luigi Warren, Pamela G. Bower, Carol B. Langer, Lawrence R. Kellerman, Christopher W. Humphreys, Bonnie I. Glanz, Elodi J. Dielubanza, Matthew P. Frosch, Roy L. Freeman, Christopher H. Gibbons, Nadia Stefanova, Tanuja Chitnis, Howard L. Weiner, Clemens R. Scherzer, Sonja W. Scholz, Dana Vuzman, Laura M. Cox, Gregor Wenning, Jeremy D. Schmahmann, Anoopum S. Gupta, Peter Novak, Geoffrey S. Young, Mel B. Feany, Tarun Singhal, Vikram Khurana
Publikováno v:
The Cerebellum.
Autor:
Alain Ndayisaba, Ariana T. Pitaro, Andrew S. Willett, Kristie A. Jones, Claudio Melo de Gusmao, Abby L. Olsen, Jisoo Kim, Eero Rissanen, Jared K. Woods, Sharan R. Srinivasan, Anna Nagy, Amanda Nagy, Merlyne Mesidor, Steven Cicero, Viharkumar Patel, Derek H. Oakley, Idil Tuncali, Katherine Taglieri-Noble, Emily C. Clark, Jordan Paulson, Richard C. Krolewski, Gary P. Ho, Albert Y. Hung, Anne-Marie Wills, Michael T. Hayes, Jason P. Macmore, Luigi Warren, Pamela G. Bower, Carol B. Langer, Lawrence R. Kellerman, Christopher W. Humphreys, Bonnie I. Glanz, Elodi J. Dielubanza, Matthew P. Frosch, Roy L. Freeman, Christopher H. Gibbons, Nadia Stefanova, Tanuja Chitnis, Howard L. Weiner, Clemens R. Scherzer, Sonja W. Scholz, Dana Vuzman, Laura M. Cox, Gregor Wenning, Jeremy D. Schmahmann, Anoopum S. Gupta, Peter Novak, Geoffrey S. Young, Mel B. Feany, Tarun Singhal, Vikram Khurana
Publikováno v:
The Cerebellum.
Multiple system atrophy (MSA) is a fatal neurodegenerative disease of unknown etiology characterized by widespread aggregation of the protein alpha-synuclein in neurons and glia. Its orphan status, biological relationship to Parkinson’s disease (PD
Autor:
Ann L. Hunt, John H. Growdon, Ganqiang Liu, Bradley T. Hyman, Joseph J. Locascio, Stephen N. Gomperts, Clemens R. Scherzer, Yuliya I. Kuras, Aleksandar Videnovic, Albert Y. Hung, Michael A. Schwarzschild, Anne-Marie Wills, Michael T. Hayes, Idil Tuncali, Todd M. Herrington, Ming Sum Ruby Chiang, Zhixiang Liao, Young Eun Huh, Karbi Choudhury, Sergio Pablo Sardi
Publikováno v:
Neurology. 95:e685-e696
ObjectiveTo test the relationship between clinically relevant types of GBA mutations (none, risk variants, mild mutations, severe mutations) and β-glucocerebrosidase activity in patients with Parkinson disease (PD) in cross-sectional and longitudina
Autor:
Clemens R. Scherzer, Anne-Marie Wills, Bradley T. Hyman, Michael A. Schwarzschild, Stephen N. Gomperts, Eric A. Macklin, Rachit Bakshi, Michael T. Hayes, Alberto Ascherio, Albert Y. Hung, John H. Growdon
Publikováno v:
J Parkinsons Dis
Two purines, caffeine and urate, have been associated with a reduced risk of idiopathic Parkinson's disease (PD) in multiple cohorts and populations. The Harvard Biomarkers Study (HBS) is a longitudinal study designed to accelerate the discovery and
Autor:
Tanya Simuni, Holly A. Shill, Matthew Brodsky, Marcie Rabin, Michael A. Schwarzschild, Kenneth Marek, Cheryl Waters, Cindy Casaceli, Steven A. Gunzler, Stephen G. Reich, Codrin Lungu, Sarah Elizabeth Zauber, Kellie Keith, Shyamal H. Mehta, Dariush Mozaffarian, Valerie Suski, Marie Saint-Hilaire, John L. Goudreau, Alice Rudolph, Ruth B. Schneider, Aaron Daley, Eric A. Macklin, Zoltan Mari, Grace F. Crotty, Andres Deik, Alberto J. Espay, Ashley Laroche, Sherri Mosovsky, Joohi Jimenez-Shahed, Mark S. LeDoux, Cynthia Poon, Ashley Gerald, John C. Morgan, Carolyn Peterson, Joseph H. Friedman, David Klements, Robert A. Hauser, Doozie Russell, David Simon, Kathrin LaFaver, Vanessa K. Hinson, Richard B. Dewey, Melissa Ainslie, Jason Aldred, Tiago A. Mestre, John Y. Fang, Liana S. Rosenthal, Grace Bwala, Raymond C. James, Binit B. Shah, Gearoid M. McMahon, Ariane Park, Rajeev Kumar, Lin Zhang, Ivan Bodis-Wollner, Mya C. Schiess, Katherine F. Callahan, David Oakes, Kelvin L. Chou, Melissa Kostrzebski, Roger Kurlan, Lisa Gauger, Albert Y. Hung, Melissa Bixby, Ira Shoulson, Michael Soileau, James T. Boyd, Peter A LeWitt, Burton L. Scott, Claire Henchcliffe, Patricia Kaminski, Alberto Ascherio, Cornelia Kamp, Lindsay Pothier, Anwar Ahmed, Jill Ciccarello, David J. Houghton, April Langhammer, Rebecca Fitzgerald, Maureen A. Leehey, Anthony E. Lang, Carmen Serrano, Martha McGraw, David Shprecher, Jennifer Durphy, Aleksandar Videnovic, Danish Bhatti, Christine Hunter, Amber Servi Ratel, J. Antonelle de Marcaida, Christopher G. Goetz, Emily Houston, Rajesh Pahwa, Chadwick W. Christine, Gary C. Curhan, Irene Litvan, Christopher A. Beck, Leslie J. Cloud, Patrick Bolger, Karen Thomas, Natividad Stover, Karen Blindauer, Sushrut S. Waikar, Susan R. Criswell
Publikováno v:
JAMA
IMPORTANCE: Urate elevation, despite associations with crystallopathic, cardiovascular, and metabolic disorders, has been pursued as a potential disease-modifying strategy for Parkinson disease (PD) based on convergent biological, epidemiological, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e4608ea519947a922d23da1991ccca9
https://europepmc.org/articles/PMC8441591/
https://europepmc.org/articles/PMC8441591/
Autor:
Mary Donovan, Krzysztof Z. Gajos, Christopher D. Stephen, Jeremy D. Schmahmann, Anoopum S. Gupta, Katharina Reinecke, Albert Y. Hung
Publikováno v:
Movement Disorders
Background Objective assessments of movement impairment are needed to support clinical trials and facilitate diagnosis. The objective of the current study was to determine if a rapid web‐based computer mouse test (Hevelius) could detect and accurat
Autor:
Albert Y. Hung, David S. Russell, Michael A. Schwarzschild, Eric A. Macklin, Marie Saint-Hilaire, Gary C. Curhan, Grace Bwala, Joshua M. Hare, Alice Rudolph, Christopher G. Goetz, Shamik Battacharyya, Rachit Bakshi, Robert Logan, John L. Goudreau, Sotirios A. Parashos, Alberto J. Espay, Alberto Ascherio
Publikováno v:
Neurology
ObjectiveTo investigate whether women and men with Parkinson disease (PD) differ in their biochemical and clinical responses to long-term treatment with inosine.MethodsThe Safety of Urate Elevation in Parkinson’s Disease (SURE-PD) trial enrolled 75
Autor:
Roger A. Barker, Claudia Trenkwalder, Sami S. Amr, Anne-Marie Wills, Christine Klein, Meike Kasten, Florence Cormier-Dequaire, Thomas G. Beach, Todd M. Herrington, Ganqiang Liu, Suzanne Lesage, Ole-Bjørn Tysnes, Clemens R. Scherzer, Jacobus J. van Hilten, Michael A. Schwarzschild, Meghan C. Campbell, Jodi Maple-Grødem, Albert Y. Hung, Zhixiang Liao, Michael T. Hayes, Jean-Christophe Corvol, Alexis Elbaz, Guido Alves, Frank Zhu, John H. Growdon, Pille Taba, Peter Heutink, Johan Marinus, Brit Mollenhauer, Joseph J. Locascio, Caroline H. Williams-Gray, Xianjun Dong, Joel S. Perlmutter, Bernard Ravina, Graziella Mangone, Alexis Brice, Ira Shoulson, Sulev Kõks, Jiajie Peng
Publikováno v:
Nature Genetics, 53(6), 787-793. NATURE RESEARCH
Nature genetics
Nature genetics 53(6), 787-793 (2021). doi:10.1038/s41588-021-00847-6
Nature genetics
Nature genetics 53(6), 787-793 (2021). doi:10.1038/s41588-021-00847-6
A key driver of patients' well-being and clinical trials for Parkinson's disease (PD) is the course that the disease takes over time (progression and prognosis). To assess how genetic variation influences the progression of PD over time to dementia,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bf0b0d7828506bc8c9a0d7770570677
https://hdl.handle.net/1887/3249471
https://hdl.handle.net/1887/3249471
Publikováno v:
Neurotherapeutics
Despite many clinical trials over the last three decades, the goal of demonstrating that a treatment slows the progression of Parkinson’s disease (PD) remains elusive. Research advances have shed new insight into cellular pathways contributing to P